218 related articles for article (PubMed ID: 18213700)
21. Serum immunoinflammation-related protein complexes discriminate between inflammatory bowel disease and colorectal cancer.
Sun YH; Li J; Shu HJ; Li ZL; Qian JM
Clin Transl Oncol; 2019 Dec; 21(12):1680-1686. PubMed ID: 30955196
[TBL] [Abstract][Full Text] [Related]
22. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease.
Bross DA; Leichtner AM; Zurakowski D; Law T; Bousvaros A
J Pediatr Gastroenterol Nutr; 1996 Aug; 23(2):164-71. PubMed ID: 8856584
[TBL] [Abstract][Full Text] [Related]
23. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
[TBL] [Abstract][Full Text] [Related]
24. Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease.
Xu M; Cen M; Chen X; Chen H; Liu X; Cao Q
Biomed Res Int; 2019; 2019():6517549. PubMed ID: 31950048
[TBL] [Abstract][Full Text] [Related]
25. Laboratory values in Japanese children with newly diagnosed inflammatory bowel disease.
Takaki Y; Mizuochi T; Eda K; Ishihara J; Yamashita Y
Pediatr Int; 2019 Jul; 61(7):720-725. PubMed ID: 31102555
[TBL] [Abstract][Full Text] [Related]
26. CD8
Dai SX; Gu HX; Lin QY; Huang SZ; Xing TS; Zhang QF; Wu G; Chen MH; Tan WE; Jian HJ; Zheng ZW; Zhong T; Zhang MH; Cheng XF; Huang P; Liao GJ; Sha WH
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):693-702. PubMed ID: 28502591
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease.
Yoshimura T; Mitsuyama K; Sakemi R; Takedatsu H; Yoshioka S; Kuwaki K; Mori A; Fukunaga S; Araki T; Morita M; Tsuruta K; Yamasaki H; Torimura T
Mediators Inflamm; 2021; 2021():8825374. PubMed ID: 33623482
[TBL] [Abstract][Full Text] [Related]
28. Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease.
Koutroubakis IE; Malliaraki N; Dimoulios PD; Karmiris K; Castanas E; Kouroumalis EA
Dig Dis Sci; 2004 Sep; 49(9):1433-7. PubMed ID: 15481315
[TBL] [Abstract][Full Text] [Related]
29. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
30. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
[TBL] [Abstract][Full Text] [Related]
31. Decreased serum fetuin-A levels and active inflammatory bowel disease.
Ma P; Feng YC
Am J Med Sci; 2014 Jul; 348(1):47-51. PubMed ID: 24487480
[TBL] [Abstract][Full Text] [Related]
32. [Inflammatory bowel disease in children--an analysis of the clinical symptoms and selected biochemical parameters].
Landowski P; Liberek A; Szlagatys-Sidorkiewicz A; Radys W; Brodzicki J; Szarszewski A; Marek A; Łuczak G; Kamińska B
Med Wieku Rozwoj; 2007; 11(4):401-7. PubMed ID: 18605192
[TBL] [Abstract][Full Text] [Related]
33. Pancreatitis-associated protein has no additional value as a marker of disease activity in a real-life cohort of IBD patients.
Bodelier AG; Pierik MJ; van den Heuvel T; Bovee-Oudenhoven IM; de Boer E; Hameeteman W; Masclee AA; Jonkers D
Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):902-9. PubMed ID: 24915490
[TBL] [Abstract][Full Text] [Related]
34. Peripheral Lymphocytes of Patients with Inflammatory Bowel Disease Have Altered Concentrations of Key Apoptosis Players: Preliminary Results.
Neubauer K; Woźniak-Stolarska B; Krzystek-Korpacka M
Biomed Res Int; 2018; 2018():4961753. PubMed ID: 30515402
[TBL] [Abstract][Full Text] [Related]
35. Association between red cell distribution width and disease activity in patients with inflammatory bowel disease.
Song CS; Park DI; Yoon MY; Seok HS; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI
Dig Dis Sci; 2012 Apr; 57(4):1033-8. PubMed ID: 22147246
[TBL] [Abstract][Full Text] [Related]
36. Low Mass Blood Peptides Discriminative of Inflammatory Bowel Disease (IBD) Severity: A Quantitative Proteomic Perspective.
Wasinger VC; Yau Y; Duo X; Zeng M; Campbell B; Shin S; Luber R; Redmond D; Leong RW
Mol Cell Proteomics; 2016 Jan; 15(1):256-65. PubMed ID: 26530476
[TBL] [Abstract][Full Text] [Related]
37. Resistin is an inflammatory marker of inflammatory bowel disease in humans.
Konrad A; Lehrke M; Schachinger V; Seibold F; Stark R; Ochsenkühn T; Parhofer KG; Göke B; Broedl UC
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831
[TBL] [Abstract][Full Text] [Related]
38. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
[TBL] [Abstract][Full Text] [Related]
39. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases.
Nikolaus S; Waetzig GH; Butzin S; Ziolkiewicz M; Al-Massad N; Thieme F; Lövgren U; Rasmussen BB; Reinheimer TM; Seegert D; Rosenstiel P; Szymczak S; Schreiber S
Int J Colorectal Dis; 2018 Jul; 33(7):927-936. PubMed ID: 29748708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
